×
For best experience we recommend to activate Javascript in your browser.
Recombinant TNFRSF10B (Tigatuzumab Biosimilar) antibody
Reactivity: Human
ELISA, BLI, FACS, Func, SPR
Host: Human
Monoclonal
unconjugated
Recombinant Antibody
Product Details anti-TNFRSF10B (Tigatuzumab Biosimilar) Antibody
(hide)
Target
See all TNFRSF10B (Tigatuzumab Biosimilar) products
TNFRSF10B (Tigatuzumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
All hosts for TNFRSF10B (Tigatuzumab Biosimilar) antibodies
Human
Expression System
CHO Cells
Clonality
All clonalities for TNFRSF10B (Tigatuzumab Biosimilar) antibodies
Monoclonal
Conjugate
All conjugates for TNFRSF10B (Tigatuzumab Biosimilar) antibodies
This TNFRSF10B (Tigatuzumab Biosimilar) antibody is un-conjugated
Application
ELISA, Bio-Layer Interferometry (BLI), Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)
Purpose
Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (tigatuzumab)
Characteristics
Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (tigatuzumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.36 kDa.
Purity
>95 %
Isotype
IgG1
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Lyophilized
Concentration
1 mg/mL
Buffer
25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
Storage
4 °C,-80 °C
Storage Comment
+4°C,-80°C
Target Details for TNFRSF10B (Tigatuzumab Biosimilar)
(hide)
Target
TNFRSF10B (Tigatuzumab Biosimilar)
Abstract
TNFRSF10B (Tigatuzumab Biosimilar) Products
Target Type
Biosimilar
Molecular Weight
145.36 kDa
UniProt
O14763
Recently viewed
(hide)